KALEIDO BIOSCIENCES, INC.
CIK 0001751299
Revenue (TTM)
$1.09M
+13.2% YoY
FY Mar 2022
Net Income (TTM)
−$93.15M
−10.6% YoY
FY Mar 2022
EPS Diluted (TTM)
—
FY Mar 2022
Gross Margin
—
FY Mar 2022
Operating Margin
-8,258.3%
FY Mar 2022
Net Margin
-8,514.4%
FY Mar 2022
Free Cash Flow (TTM)
−$76.64M
FY Mar 2022
Cash
$38.47M
FY Mar 2022
Total Debt
$21.69M
FY Mar 2022
Shares Outstanding
42.62M sh
FY Mar 2022